Journal article icon

Journal article

Systematic review and meta-analysis: Prevalence, risk factors, and costs of aminosalicylate use in Crohn’s disease

Abstract:

Background

Aminosalicylates are the most frequently prescribed drugs for patients with Crohn’s disease (CD), yet evidence to support their efficacy as induction or maintenance therapy is controversial.

Aims

To quantify aminosalicylate use in CD clinical trials, identify factors associated with use, and estimate direct annual treatment costs of therapy.

Methods

MEDLINE, Embase, and CENTRAL were searched to April 2017 for placebo-controlled trials in...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted Manuscript

Actions


Access Document


Files:
Publisher copy:
10.1111/apt.14821

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDORMS; CSM
Oxford college:
St Johns College
Role:
Author
ORCID:
0000-0003-4573-5257
Expand authors...
Canadian Association of Gastroenterology More from this funder
Canadian Institutes of Health Research More from this funder
American College of Gastroenterology More from this funder
Crohn’s and Colitis Foundation More from this funder
Publisher:
Wiley Publisher's website
Journal:
Alimentary Pharmacology & Therapeutics Journal website
Volume:
48
Issue:
2
Pages:
114-126
Publication date:
2018-05-30
Acceptance date:
2018-05-02
DOI:
EISSN:
1365-2036
ISSN:
0269-2813
Pubs id:
pubs:854304
URN:
uri:854e71cc-5c35-444d-a242-9713136c5481
UUID:
uuid:854e71cc-5c35-444d-a242-9713136c5481
Local pid:
pubs:854304

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP